Health Care & Life Sciences » Pharmaceuticals | Panacea Biotec Ltd.

Panacea Biotec Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
4,974
6,752
6,258
5,339
5,928
Cost of Goods Sold (COGS) incl. D&A
5,085
5,527
4,465
3,975
3,974
Gross Income
111
1,225
1,794
1,364
1,954
SG&A Expense
1,345
1,263
1,510
1,274
1,694
EBIT
1,513
75
329
106
260
Unusual Expense
1,752
200
446
72
-
Non Operating Income/Expense
82
110
254
345
82
Interest Expense
1,503
1,045
1,270
1,117
1,006
Pretax Income
1,110
994
189
567
664
Income Tax
17
31
19
37
99
Equity in Affiliates
6
58
2
51
2
Consolidated Net Income
1,132
1,083
206
655
760
Net Income
1,121
1,065
183
645
760
Net Income After Extraordinaries
1,121
1,065
183
645
760
Net Income Available to Common
1,121
1,065
183
645
760
EPS (Basic)
18.31
17.39
2.99
10.52
12.41
Basic Shares Outstanding
61
61
61
61
-
EPS (Diluted)
18.31
17.39
2.99
10.52
-
Diluted Shares Outstanding
61
61
61
61
-
EBITDA
802
598
1,062
783
845
Other Operating Expense
57
37
46
16
-
Non-Operating Interest Income
74
37
51
27
-
Minority Interest Expense
11
18
23
11
-

About Panacea Biotec

View Profile
Address
B-1 Extn., G-3
New Delhi Delhi 110044
India
Employees -
Website http://www.panaceabiotec.com
Updated 09/14/2018
Panacea Biotec Ltd. is engaged in the business of research, development, manufacture and marketing of vaccines and pharmaceutical formulations. Its products covers supports a range of medical areas such as renal disease management, nephrology, oncology, diabetes management and pediatric vaccines. It operates through the following segments: Vaccines, Formulations, Research and Developmen, Healthcare, and Real Estate.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.